Literature DB >> 15760680

Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice.

Kaori Sudo1, Yasuhiro Yamada, Hisataka Moriwaki, Kuniaki Saito, Mitsuru Seishima.   

Abstract

Chronic liver injury causes liver regeneration, resulting in fibrosis. The proinflammatory cytokine tumor necrosis factor (TNF) is involved in the pathogenesis of many acute and chronic liver diseases. TNF has pleiotropic functions, but its role in liver fibrosis has not been clarified. Chronic repeated injection of CCl4 induces liver fibrosis in mice. We examined whether signaling through TNF receptors was critical for this process, using mice lacking either TNF receptor (TNFR) type 1 or TNFR type 2 to define the pathophysiologic role of TNFR signals in liver fibrosis. Liver fibrosis caused by chronic CCl4 exposure was TNF-dependent; histological fibrosis was seen in wild-type (WT) and TNFR-2 knockout (KO) mice, but not in TNFR-1 KO mice. Furthermore, a marked reduction in procollagen and TGF-beta synthesis was observed in TNFR-1 KO mice, which also had little detectable NF-kappa B, STAT3, and AP1 binding, and reduced levels of liver interleukin-6 (IL-6) mRNA compared to WT and TNFR-2 KO mice. In conclusion, our results indicate the possibility that NF-kappa B, STAT3, and AP1 binding by signals transduced through TNFR-1 plays an important role in liver fibrosis formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15760680     DOI: 10.1016/j.cyto.2004.11.001

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  27 in total

1.  Hepatocyte-specific ablation of spermine/spermidine-N1-acetyltransferase gene reduces the severity of CCl4-induced acute liver injury.

Authors:  Kamyar Zahedi; Sharon L Barone; Jie Xu; Nora Steinbergs; Rebecca Schuster; Alex B Lentsch; Hassane Amlal; Jiang Wang; Robert A Casero; Manoocher Soleimani
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-21       Impact factor: 4.052

2.  TNFα in liver fibrosis.

Authors:  Yoon Mee Yang; Ekihiro Seki
Journal:  Curr Pathobiol Rep       Date:  2015-09-30

3.  Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats.

Authors:  Shuang-Suo Dang; Bao-Feng Wang; Yan-An Cheng; Ping Song; Zhen-Guo Liu; Zong-Fang Li
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

4.  Proanthocyanidin-rich date seed extract protects against chemically induced hepatorenal toxicity.

Authors:  Atallah F Ahmed; Jawaher H Al-Qahtani; Hanan M Al-Yousef; Mansour S Al-Said; AbdelKader E Ashour; Mohammed Al-Sohaibani; Syed Rafatullah
Journal:  J Med Food       Date:  2015-01-08       Impact factor: 2.786

Review 5.  Molecular and cellular mechanisms of liver fibrosis and its regression.

Authors:  Tatiana Kisseleva; David Brenner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-30       Impact factor: 46.802

6.  B cells: no longer bystanders in liver fibrosis.

Authors:  Rashpal K Bhogal; Constantin A Bona
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

7.  TNFalpha is required for cholestasis-induced liver fibrosis in the mouse.

Authors:  Erwin Gäbele; Matthias Froh; Gavin E Arteel; Takehiko Uesugi; Claus Hellerbrand; Jürgen Schölmerich; David A Brenner; Ronald G Thurman; Richard A Rippe
Journal:  Biochem Biophys Res Commun       Date:  2008-11-06       Impact factor: 3.575

8.  Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice.

Authors:  Phillipp Hartmann; Michael Haimerl; Magdalena Mazagova; David A Brenner; Bernd Schnabl
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

9.  Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice.

Authors:  Vincent E de Meijer; Deanna Y Sverdlov; Yury Popov; Hau D Le; Jonathan A Meisel; Vânia Nosé; Detlef Schuppan; Mark Puder
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

10.  Hepatoprotective effect of infliximab, an anti-TNF-alpha agent, on carbon tetrachloride-induced hepatic fibrosis.

Authors:  Ibrahim Halil Bahcecioglu; Suleyman Serdar Koca; Orhan Kursat Poyrazoglu; Mehmet Yalniz; Ibrahim Hanifi Ozercan; Bilal Ustundag; Kazim Sahin; Adile Ferda Dagli; Ahmet Isik
Journal:  Inflammation       Date:  2008-04-22       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.